Innoviva - Stock Price History | INVA

Historical daily share price chart and data for Innoviva since 2020 adjusted for splits. The latest closing stock price for Innoviva as of August 03, 2020 is 13.81.
  • The all-time high Innoviva stock closing price was 20.06 on January 29, 2019.
  • The Innoviva 52-week high stock price is 15.62, which is 13.1% above the current share price.
  • The Innoviva 52-week low stock price is 7.58, which is 45.1% below the current share price.
  • The average Innoviva stock price for the last 52 weeks is 12.82.
Innoviva Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 13.6159 17.3000 20.0600 10.0500 14.1600 -18.85%
2018 15.2612 14.4300 18.2600 13.4400 17.4500 22.97%
2017 12.7225 11.1400 14.7500 10.4300 14.1900 32.62%
2016 11.2728 9.8800 13.7700 8.2300 10.7000 0.00%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $1.399B $0.261B
Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company's portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance, Inc., is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $387.947B 18.49
Roche Holding AG (RHHBY) Switzerland $302.429B 0.00
Pfizer (PFE) United States $213.028B 13.32
Merck (MRK) United States $208.339B 14.90
Novartis AG (NVS) Switzerland $191.450B 14.88
Novo Nordisk (NVO) Denmark $154.051B 25.66
AstraZeneca (AZN) United Kingdom $149.117B 28.99
Eli Lilly (LLY) United States $146.187B 22.31
AbbVie (ABBV) United States $141.679B 10.32
Sanofi (SNY) $133.245B 15.84
GlaxoSmithKline (GSK) United Kingdom $103.577B 13.58
Bayer (BAYRY) Germany $64.831B 9.24
H Lundbeck (HLUYY) Denmark $7.412B 12.88